Agilent Technologies Inc. (A)
Company Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.
The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.
The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.
Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Country | United States |
IPO Date | Nov 18, 1999 |
Industry | Medical - Diagnostics & Research |
Sector | Healthcare |
Employees | 18,000 |
CEO | Padraig McDonnell |
Contact Details
Address: 5301 Stevens Creek Boulevard Santa Clara, California United States | |
Website | https://www.agilent.com |
Stock Details
Ticker Symbol | A |
Exchange | NYSE |
Fiscal Year | November - October |
Reporting Currency | USD |
CIK Code | 0001090872 |
CUSIP Number | 00846U101 |
ISIN Number | US00846U1016 |
Employer ID | 77-0518772 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Padraig McDonnell | Chief Executive Officer, President & Director |
Bret M. DiMarco | Senior Vice President, Chief Legal Officer, & Secretary |
Robert W. McMahon C.M.A. | Senior Vice President & Chief Financial Officer |
Chris Swenson | Vice President & Interim Chief Human Resources Officer |
Dr. Simon May | SVice President & President of LDG |
Frederick Schwarz | SVice President, Chief Strategy & Corporate Development Officer |
Henrik Ancher-Jensen | Senior Vice President and President of Order Fulfillment & Supply Chain |
Parmeet Ahuja | Vice President of Investor Relations |
Rodney Gonsalves | Principal Accounting Officer, Vice President & Corporate Controller |
Yvonne Mackie | MD of UK & Ireland Operations and Vice President of Human Resources - Europe |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 26, 2025 | 8-K | Current Report |
Feb 21, 2025 | DEFA14A | Filing |
Feb 13, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Jan 31, 2025 | DEFA14A | Filing |
Jan 31, 2025 | ARS | Filing |
Jan 31, 2025 | DEF 14A | Filing |
Jan 30, 2025 | 4 | Filing |
Jan 23, 2025 | 4 | Filing |
Jan 14, 2025 | PRE 14A | Filing |
Dec 20, 2024 | 10-K | Annual Report |